Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus

Hepatocellular carcinoma (HCC) patients with main portal vein tumor thrombus have a median survival time of only about 4 months. We therefore compared the safety and efficacy of endovascular brachytherapy (EVBT) and sequential three-dimensional conformal radiotherapy (3-DCRT). From a cohort of 176 p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Yu, Tian-Zhu, Zhang, Wen, Liu, Qing-Xin, Li, Wen-Hui, Ma, Jing-Qin, Zhang, Zi-Han, Yang, Min-Jie, Wang, Jian-Hua, Chen, Bing, Zeng, Shao-Chong, Luo, Jian-Jun, Liu, Ling-Xiao, Yan, Zhi-Ping
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355329/
https://ncbi.nlm.nih.gov/pubmed/28076848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14520
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky